Brief: Volitionrx Reports Cash And Cash Equivalents As Of March 31, 2023 At $10 Million
10/05/2023 23:00
May 10 (Reuters) - VolitionRX Ltd VNRX.A :
* VOLITIONRX LTD - CASH AND CASH EQUIVALENTS AS OF MARCH 31,
2023,
TOTALED ABOUT $10 MILLION
Source text for Eikon: ID:nPn22HHMsa
Further company coverage: VNRX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems